Certified by Founder Lodge
Artax Biopharma Inc
United States - Cambridge, MA
START UP
1 Disclosed Funding Rounds $8,000,000
0 Participating Investments
-
Founded date
2013
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Artax Biopharma is a development-stage biopharmaceutical company dedicated to the development of new therapies for autoimmune and inflammatory diseases. Artax Biopharma is developing the next
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| August, 07 ,2024 | Unknown | $8,000,000 |
Eli Lilly and Company
Advent Life Sciences
Sound Bioventures
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
